Related Experiment Video
Updated: May 10, 2026

08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases
Hilary Anne Archer1, Aikaterini Panopoulou, Nidhi Bhatt
1Department of Neurosciences, Frenchay Hospital, Bristol, UK.
Practical Neurology
|June 11, 2013
Abstract:
We present a patient with opsoclonus and diffuse cerebellar signs who had an anti-Ma2 antibody-associated paraneoplastic syndrome secondary to a sarcomatoid mesothelioma. This case highlights the importance of early tumour detection, instigation of therapeutic measures, and the heterogeneity of underlying malignancies in neurological paraneoplastic syndromes.

